This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Regulator in China's Jilin steps up enforcement against unfair competition by online platforms, drug distributors

( June 17, 2021, 07:59 GMT | Official Statement) -- MLex Summary: The Jilin provincial Administration for Market Regulation will enhance enforcement against online platform operators and pharmaceutical distributors that have engaged in unfair competition, the regulator said in a statement. In a campaign that will last until the end of the year, the regulator will crack down on platform operators imposing exclusivity requirements and using technical means to impede the normal operation of other businesses. The regulator will also act against drug distributors that provide rebates, bundle the sale of drugs and medical consumables together, and engage in commercial bribery and false advertising.The statement follows:...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections